Cas:12080-32-9 Dichloro(1,5-cyclooctadiene)platinum(II) manufacturer & supplier

Chemical Name:Dichloro(1,5-cyclooctadiene)platinum(II)

CAS.NO:12080-32-9

Synonyms:(1Z,5Z)-1,5-Cyclooctadiene – dichloroplatinum (1:1);(1,5-Cyclooctadiene)platinum(II) dichloride;(1Z,5Z)-Cycloocta-1,5-diene – dichloroplatinum (1:1);(5Z)-Cycloocta-1,5-diene – dichloroplatinum (1:1);1,5-Cyclooctadienedichloroplatinum;Platinum, dichloro(1,5-cyclooctadiene)-;Dichloro(1,5-cyclooctadiene)platinum(II);EINECS 235-144-5;MFCD00012413;1,5-Cyclooctadieneplatinum(II) Dichloride

Molecular Formula:C₈H₁₂Cl₂Pt

Molecular Weight:374.171

HS Code:

Physical and Chemical Properties:

Melting point:285ºC (dec.)

Boiling point:153.5ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:

Exact Mass:372.996399

LogP:3.55730

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (1Z,5Z)-1,5-Cyclooctadiene – dichloroplatinum (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,5-Cyclooctadieneplatinum(II) Dichloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EINECS 235-144-5 Use and application,MFCD00012413 technical grade,usp/ep/jp grade.

Related News: The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems. methyl (Z)-2-(2-phenyl-4H-benzo[d][1,3]oxazin-4-ylidene)acetate manufacturers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 Pyrrolidine, 1-[[(4-methylphenyl)sulfonyl]thioxomethyl]- suppliers developing a New Deal for post-graduate research students, starting later this year with a cross-sectoral consultation led by UKRI Ethyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-nitro-L-phenylalan inate vendor & factory As of June’s end, there have been 100 reported GBS cases among J&J recipients, most of whom were hospitalized and one person has died, CDC officials reported. Most cases were seen in older men within 13 days following the single-dose vaccine. ,It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached.